Form 8-K - Current report:
SEC Accession No. 0001144204-16-121529
Filing Date
2016-08-26
Accepted
2016-08-26 17:13:26
Documents
3
Period of Report
2016-08-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v447754_8k.htm 8-K 20620
2 EXHIBIT 1.1 v447754_ex1-1.htm EX-1.1 247513
3 EXHIBIT 5.1 v447754_ex5-1.htm EX-5.1 8960
  Complete submission text file 0001144204-16-121529.txt   278530
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 161855494
SIC: 2834 Pharmaceutical Preparations